FDA Adverse Event Injury Summary report: N

SPRINT FIDELIS

MDR report key: 2952320 · Received February 9, 2013

Report

Report Number
2649622-2013-00497
Event Type
Injury
Date Received
February 9, 2013
Report Date
November 16, 2012
Manufacturer
MPRI
Product Code
LWS
PMA / PMN Number
P920015
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT EVALUATION SUMMARY: THE ACTUAL LEAD WAS NOT RECEIVED FOR EVALUATION. WE DID RECEIVE PERFORMANCE DATA COLLECTED FROM THE DEVICE AND HAVE ANALYZED THE DATA. ANALYSIS FOUND THAT THERE WAS HIGH RESISTANCE/IMPEDANCE WITH PATIENT ALERTS FOR RIGHT VENTRICULAR PACE LEAD IMPEDANCE ON (B)(6) 2012. WEEKLY PACE LEAD TREND DATA SHOWS AN ABRUPT INCREASE FOR MIN AND MAX V. PACE EQUAL TO 888 TO 2176 OHMS PEAK BETWEEN (B)(6) 2012. OVERSENSING WITH VENTRICULAR NON-SUSTAINED TACHYCARDIA LESS THAN EQUAL TO 210 MS ON (B)(6) 2012. ALSO, THERE WAS INTERFERENCE NOISE WITH VENTRICULAR SHORT INTERVAL COUNT (V-SIC) EQUAL TO 3765 COUNTS, IN 6.24 DAYS, BETWEEN (B)(6) 2012.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US WHERE THE SAME MODEL IS DISTRIBUTED. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE RIGHT VENTRICULAR (RV) LEAD HAD IMPEDANCE GREATER THAN 2000 OHMS, OVERSENSING AND A SUSPECTED LEAD FRACTURE. IT WAS ALSO DETERMINED THAT THE RV LEAD WAS IMPLANTED APPROXIMATELY A MONTH AFTER THE USE BEFORE DATE. THE RV LEAD WAS GOING TO BE SURGICALLY REVISED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
56563 SPRINT FIDELIS DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER LWS MPRI 694865

Patients

Seq Age Sex Outcome Treatment
1 00051 YR Hospitalization| R